Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Trelagliptin (100mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x1x4
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Trelanip 100 Tablet contains Trelagliptin 100mg, a once-weekly oral antidiabetic medication that belongs to the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class. It functions by inhibiting the DPP-4 enzyme, thereby increasing the levels of active incretin hormones such as GLP-1 and GIP. These hormones help regulate blood glucose levels by enhancing glucose-dependent insulin secretion and suppressing glucagon release. The long half-life of Trelagliptin enables weekly dosing, which improves patient compliance and simplifies diabetes management. It does not typically cause weight gain and has a low risk of hypoglycemia when used as monotherapy.
Possible side effects include headache, nasopharyngitis, upper respiratory tract infection, and gastrointestinal upset. Hypoglycemia is rare but may occur when used with insulin or sulfonylureas. Allergic skin reactions, though uncommon, may also develop.
Trelanip 100 is indicated for adults with type 2 diabetes mellitus to improve glycemic control, especially when diet and exercise alone are insufficient. It may be used as monotherapy or in combination with other antidiabetic drugs, such as metformin, sulfonylureas, or thiazolidinediones.
Trelanip 100 should be used under medical supervision, particularly in patients with renal or hepatic impairment. It is not indicated for type 1 diabetes mellitus or diabetic ketoacidosis. Patients should monitor blood glucose levels regularly and report any unusual symptoms to their physician.
Store in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep out of reach of children.
Composition : Trelagliptin (25mg) Tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Trelagliptin 100mg Tablet has growing demand in the diabetology, endocrinology, general medicine, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on innovative anti-diabetic and specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from increasing demand for Type 2 diabetes management under healthcare professional supervision. Trelagliptin 100mg is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps improve glycemic control by increasing endogenous incretin hormone activity, thereby enhancing glucose-dependent insulin secretion and reducing glucagon release Commonly prescribed as an adjunct to diet and exercise for the management of Type 2 Diabetes Mellitus in adults, as advised by healthcare professionals and approved prescribing information Trelagliptin is distinguished by its once-weekly oral dosing regimen, which may help improve patient adherence in appropriate individuals Can be used as monotherapy or in combination with other antidiabetic medicines when clinically indicated, according to treatment guidelines and individual patient needs Should be used under medical supervision with regular monitoring of blood glucose and HbA1c, along with appropriate lifestyle modifications. It is not indicated for Type 1 diabetes mellitus or diabetic ketoacidosis Frequently utilized in diabetology clinics, endocrinology practices, general medicine departments, and chronic disease management programs Widely prescribed by diabetologists, endocrinologists, and general physicians for appropriate patients with Type 2 diabetes This strengthens a comprehensive anti-diabetic and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Trelagliptin 100mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from growing demand in the diabetes care market, increasing acceptance of innovative once-weekly oral therapies, reliable supply chain support, repeat prescriptions, and attractive margins in the chronic care segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality anti-diabetic products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.